JULIE HOWELL-CLEMMER: Open Payments
NPI 1699482141 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 18 payments from 9 companies in 2025. Trend: 2023 $212 · 2024 $507 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $88 |
| ABBVIE INC. | 3 | $66 |
| Organogenesis Inc. | 2 | $49 |
| PFIZER INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: Wegovy, QULIPTA, PURAPLY WOUND MATRIX, PREVNAR 20, Ozempic, REXULTI, Symbravo, CAPVAXIVE.
Industry payments across FL — which companies pay providers there.
